Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration
Condition(s):Methylprednisolone; Intranasal Administration; Patients With an Active Multiple Sclerosis RelapseLast Updated:January 25, 2024Enrolling by invitation